Magentus partners with Amgen Australia to deliver AI-powered dermatology tool

September 27, 2024 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

Health technology company Magentus is partnering with Amgen in pioneering a new era in dermatology patient care with the launch of a data-driven tool designed to help dermatologists improve outcomes for psoriasis patients. …

Subscribe now to continue reading.

Latest Video

The lesson to learn from the Guild is that you cannot defeat what you do not know
December 14, 2025 - Latest News
Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis
December 15, 2025 - Latest News
GBMA to host inaugural summit aimed at addressing medicine shortages
December 15, 2025 - Latest News
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - Latest News
Novartis names new Country President following leadership transition
December 16, 2025 - Latest News

Magentus partners with Amgen Australia to deliver AI-powered dermatology tool

This is a preview of subscriber content

Latest Video

Most Read

The lesson to learn from the Guild is that you cannot defeat what you do not know

Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis

GBMA to host inaugural summit aimed at addressing medicine shortages

The industry is probably right to resist, it just needs to prepare for the response

Novartis names new Country President following leadership transition

New Stories

OncoSil completes first production run at new Sydney manufacturing facility

Island Pharmaceuticals secures key partnership with Texas Biomed

Novartis names new Country President following leadership transition

Mayne Pharma opens expanded manufacturing facility after termination of takeover

Budget update includes impact of listings, but generally not much else

The UK reconfirms the direct impact of the transatlantic shift in medicine pricing

The industry is probably right to resist, it just needs to prepare for the response

Sign In

Magentus partners with Amgen Australia to deliver AI-powered dermatology tool

This is a preview of subscriber content

Latest Video

Most Read

The lesson to learn from the Guild is that you cannot defeat what you do not know

Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis

GBMA to host inaugural summit aimed at addressing medicine shortages

The industry is probably right to resist, it just needs to prepare for the response

Novartis names new Country President following leadership transition

Follow Us

New Stories

OncoSil completes first production run at new Sydney manufacturing facility

Island Pharmaceuticals secures key partnership with Texas Biomed

Novartis names new Country President following leadership transition

Mayne Pharma opens expanded manufacturing facility after termination of takeover

Budget update includes impact of listings, but generally not much else

The UK reconfirms the direct impact of the transatlantic shift in medicine pricing

The industry is probably right to resist, it just needs to prepare for the response